Summary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…
Tag:
Efgartigimod
-
-
Global MarketRegulatoryU.S FDA
Swiss drugmaker Idorsia’s insomnia medicine gets US FDA’s approval
by adminby adminSummary : The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg…
-
AgrochemicalsArgenx
Argenx Snags First US. FDA Approval With Vyvgart (efgartigimod alfa-fcab) win in Generalized Myasthenia Gravis
by adminby adminSynopsis: VYVGART is the first-and-only FDA-approved neonatal Fc receptor blocker 68% of anti-acetylcholine receptor (AChR) antibody positive gMG patients treated with VYVGART…